According to FibroBiologics's latest financial reports the company has $9.16 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $9.16 M | 304.37% |
2022-12-31 | $2.26 M | 456.76% |
2021-12-31 | $0.4 M |